Pb2+ reduces PKCs and NF-kappaB in vitro

Area of Science:

• Neuroscience
• Toxicology
• Molecular Biology

Background:

• Lead (Pb(2+)) neurotoxicity mechanisms remain unclear.
• Protein kinase C (PKC) and nuclear factor-kappaB (NF-kappaB) pathways are crucial in neuronal function.
• Understanding lead's impact on these pathways is vital for neuroprotection.

Purpose of the Study:

• To investigate the effects of Pb(2+) on various PKC isoforms in cultured neurons.
• To examine Pb(2+) influence on the NF-kappaB-I-kappaB kinase-alpha (IKK-alpha) axis.
• To elucidate the molecular mechanisms underlying lead-induced neurotoxicity.

Main Methods:

• Primary neuronal cultures from rat fetal brains.
• Exposure to varying concentrations of Pb(2+) (10(-10) to 10(-7) mol/L) for 14 hours.
• Immunoprecipitation and Western blotting to quantify PKC isoforms, NF-kappaB (p50), and IKK-alpha.
• Assay of total, calcium-dependent, and calcium-independent PKC activities.

Main Results:

• Pb(2+) significantly reduced PKC isoforms (alpha, beta, gamma, epsilon, lambda) in a dose-dependent manner, sparing PKC delta.
• Total, calcium-dependent, and calcium-independent PKC activities were inhibited by Pb(2+).
• Pb(2+) dose-dependently decreased NF-kappaB (p50) and IKK-alpha protein levels.

Conclusions:

• Pb(2+) differentially affects PKC isoforms but consistently inhibits the NF-kappaB-IKK-alpha signaling axis.
• These findings suggest specific molecular targets for lead neurotoxicity.
• Further research into these pathways may reveal therapeutic strategies against lead poisoning.